{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# AI-Enhanced Regulatory Compliance Validator Demo\n",
    "\n",
    "This notebook demonstrates an AI-powered A2A agent that validates clinical trial protocols against:\n",
    "- **HIPAA** Privacy and Security Rules\n",
    "- **21 CFR Part 11** Electronic Records/Signatures\n",
    "- **IRB** Requirements\n",
    "- **ONC HTI-1** Transparency Requirements\n",
    "\n",
    "## Key Features:\n",
    "- ü§ñ **AI-Powered Analysis**: Uses LLM to understand context and reduce false positives\n",
    "- üìä **Confidence Scoring**: Each finding has a confidence score (0-100%)\n",
    "- üéØ **Smart Detection**: Distinguishes between mentions and actual violations\n",
    "- üìù **Detailed Explanations**: AI explains WHY something is or isn't compliant"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Setup and Configuration"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ OpenAI API key found\n",
      "\n",
      "‚úÖ AI-Enhanced Regulatory Compliance Agent imported successfully\n"
     ]
    }
   ],
   "source": [
    "# Import required libraries\n",
    "import sys\n",
    "import os\n",
    "import asyncio\n",
    "from pathlib import Path\n",
    "from IPython.display import display, HTML, Markdown\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "\n",
    "# Add parent directory to path\n",
    "sys.path.insert(0, str(Path('.').absolute()))\n",
    "\n",
    "# Check for LLM API keys\n",
    "api_status = []\n",
    "if os.getenv('OPENAI_API_KEY'):\n",
    "    api_status.append('‚úÖ OpenAI API key found')\n",
    "if os.getenv('GOOGLE_API_KEY'):\n",
    "    api_status.append('‚úÖ Google API key found')\n",
    "if os.getenv('ANTHROPIC_API_KEY'):\n",
    "    api_status.append('‚úÖ Anthropic API key found')\n",
    "\n",
    "if not api_status:\n",
    "    display(HTML(\"\"\"\n",
    "    <div style=\"background-color: #ffe4b5; padding: 15px; border-radius: 10px; border-left: 5px solid #ff8c00;\">\n",
    "        <h3 style=\"color: #d2691e; margin-top: 0;\">‚ö†Ô∏è No LLM API Key Detected</h3>\n",
    "        <p>For AI-enhanced analysis, please set one of the following environment variables:</p>\n",
    "        <ul>\n",
    "            <li>OPENAI_API_KEY</li>\n",
    "            <li>GOOGLE_API_KEY</li>\n",
    "            <li>ANTHROPIC_API_KEY</li>\n",
    "        </ul>\n",
    "        <p>The agent will fall back to pattern-only detection without AI analysis.</p>\n",
    "    </div>\n",
    "    \"\"\"))\n",
    "else:\n",
    "    for status in api_status:\n",
    "        print(status)\n",
    "\n",
    "# Import the AI-enhanced compliance agent\n",
    "from examples.regulatory_compliance_ai_agent import RegulatoryComplianceAIAgent\n",
    "\n",
    "print(\"\\n‚úÖ AI-Enhanced Regulatory Compliance Agent imported successfully\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:01:51,951 - base.base_agent - INFO - üöÄ Initializing RegulatoryComplianceAIAgent\n",
      "2025-08-12 11:01:51,952 - base.base_agent - INFO - üìä Loading environment configuration...\n",
      "2025-08-12 11:01:51,969 - base.base_agent - INFO - üîë Google API Key: ‚ùå Missing\n",
      "2025-08-12 11:01:51,970 - base.base_agent - INFO - üîë OpenAI API Key: ‚úÖ Configured\n",
      "2025-08-12 11:01:51,971 - base.base_agent - INFO - üîë Anthropic API Key: ‚ùå Missing\n",
      "2025-08-12 11:01:51,972 - base.base_agent - INFO - ‚úÖ Auto-selected provider: openai\n",
      "2025-08-12 11:01:51,974 - base.base_agent - INFO - üéØ Selected provider: openai with model: gpt-4o-mini\n",
      "2025-08-12 11:01:51,975 - base.base_agent - INFO - üë§ Agent user ID: AI Regulatory Compliance Validator_user\n",
      "2025-08-12 11:01:51,976 - base.base_agent - INFO - üîß Building LLM agent...\n",
      "2025-08-12 11:01:51,976 - base.base_agent - INFO - üìù Creating agent-specific system instructions...\n",
      "2025-08-12 11:01:51,976 - base.base_agent - INFO - üõ†Ô∏è Registering 0 tools...\n",
      "2025-08-12 11:01:51,977 - base.base_agent - INFO - üî® Creating LlmAgent instance...\n",
      "2025-08-12 11:01:51,977 - base.base_agent - INFO - üîÑ Using LiteLLM for openai model: gpt-4o-mini\n",
      "2025-08-12 11:01:51,999 - base.base_agent - INFO - ‚úÖ LlmAgent created: ai_regulatory_compliance_validator\n",
      "2025-08-12 11:01:52,000 - base.base_agent - INFO - ‚úÖ LLM agent 'ai_regulatory_compliance_validator' created successfully\n",
      "2025-08-12 11:01:52,001 - base.base_agent - INFO - üèÉ Creating runner with session management services...\n",
      "2025-08-12 11:01:52,005 - base.base_agent - INFO - üìù Session management services initialized\n",
      "2025-08-12 11:01:52,007 - base.base_agent - INFO - üíì Heartbeat interval: 10.0s\n",
      "2025-08-12 11:01:52,007 - base.base_agent - INFO - ‚è±Ô∏è Chunk timeout: 120.0s\n",
      "2025-08-12 11:01:52,008 - base.base_agent - INFO - üíª Running in local development mode\n",
      "2025-08-12 11:01:52,009 - base.base_agent - INFO - ‚úÖ RegulatoryComplianceAIAgent initialization complete!\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #f0f8ff; padding: 15px; border-radius: 10px; border-left: 5px solid #4169e1;\">\n",
       "    <h3 style=\"color: #2c3e50; margin-top: 0;\">ü§ñ AI-Enhanced Agent Initialized</h3>\n",
       "    <p><strong>Name:</strong> AI Regulatory Compliance Validator</p>\n",
       "    <p><strong>Description:</strong> AI-enhanced validation of clinical trial protocols against HIPAA, 21 CFR Part 11, IRB requirements, and ONC HTI-1 transparency rules. Uses advanced AI analysis to accurately identify violations and provide detailed compliance reports with risk assessments and recommendations.</p>\n",
       "    <p><strong>System Instruction Preview:</strong><br>\n",
       "    <em>You are an expert regulatory compliance analyst specializing in healthcare \n",
       "        and clinical trials. Your role is to analyze text excerpts and determine if they \n",
       "        represent actual regulator...</em></p>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Initialize the AI-enhanced agent\n",
    "agent = RegulatoryComplianceAIAgent()\n",
    "\n",
    "display(HTML(f\"\"\"\n",
    "<div style=\"background-color: #f0f8ff; padding: 15px; border-radius: 10px; border-left: 5px solid #4169e1;\">\n",
    "    <h3 style=\"color: #2c3e50; margin-top: 0;\">ü§ñ AI-Enhanced Agent Initialized</h3>\n",
    "    <p><strong>Name:</strong> {agent.get_agent_name()}</p>\n",
    "    <p><strong>Description:</strong> {agent.get_agent_description()}</p>\n",
    "    <p><strong>System Instruction Preview:</strong><br>\n",
    "    <em>{agent.get_system_instruction()[:200]}...</em></p>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Demo 1: Compliant Protocol\n",
    "\n",
    "Let's test with a protocol that properly implements security measures:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:01:57,857 - examples.regulatory_compliance_ai_agent - INFO - Starting AI-enhanced regulatory compliance validation\n",
      "2025-08-12 11:01:57,860 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with HIPAA using AI analysis\n",
      "2025-08-12 11:01:57,880 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,881 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,882 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,884 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for HIPAA\n",
      "2025-08-12 11:01:57,885 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with 21 CFR Part 11 using AI analysis\n",
      "2025-08-12 11:01:57,886 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,888 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for 21 CFR Part 11\n",
      "2025-08-12 11:01:57,888 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with IRB using AI analysis\n",
      "2025-08-12 11:01:57,890 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,892 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,893 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for IRB\n",
      "2025-08-12 11:01:57,894 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with ONC HTI-1 using AI analysis\n",
      "2025-08-12 11:01:57,895 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110157\n",
      "2025-08-12 11:01:57,897 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for ONC HTI-1\n",
      "2025-08-12 11:01:57,898 - examples.regulatory_compliance_ai_agent - INFO - AI compliance validation complete. Risk score: 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üîç Analyzing COMPLIANT protocol...\n",
      "Expected: Should find few or no violations\n",
      "\n",
      "‚û§ Risk Score: 0/100 üü¢\n",
      "‚û§ Total Issues Found: 0\n",
      "‚û§ High Confidence Issues (‚â•80%): 0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #e6ffe6; padding: 15px; border-radius: 10px; border-left: 5px solid #228b22; margin-top: 20px;\">\n",
       "    <h4 style=\"color: #006400;\">‚úÖ Compliant Protocol Results</h4>\n",
       "    <p>The AI correctly recognizes that security measures ARE properly implemented.</p>\n",
       "    <p>This demonstrates the AI's ability to understand context and avoid false positives.</p>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Example of a COMPLIANT protocol\n",
    "COMPLIANT_PROTOCOL = \"\"\"\n",
    "CLINICAL TRIAL DATA MANAGEMENT PROTOCOL\n",
    "\n",
    "1. DATA SECURITY IMPLEMENTATION\n",
    "Our trial implements comprehensive HIPAA-compliant security measures:\n",
    "- All 18 HIPAA identifiers are removed using Safe Harbor de-identification\n",
    "- AES-256 encryption is active for all data at rest\n",
    "- TLS 1.3 is configured for all data transmission\n",
    "- Comprehensive audit logs track every PHI access with timestamp and user ID\n",
    "\n",
    "2. ELECTRONIC RECORDS (21 CFR Part 11)\n",
    "Our electronic data capture system has:\n",
    "- Completed full IQ/OQ/PQ validation with documented results\n",
    "- Electronic signatures include printed name, date/time, and meaning\n",
    "- Secure, time-stamped audit trails maintained for all changes\n",
    "- System access controlled via multi-factor authentication\n",
    "\n",
    "3. IRB COMPLIANCE\n",
    "The protocol has been reviewed and approved:\n",
    "- Full IRB approval obtained from all participating sites\n",
    "- Informed consent forms include all 8 required elements per 45 CFR 46.116\n",
    "- Data Safety Monitoring Board (DSMB) established and meeting quarterly\n",
    "- Risk assessment completed with mitigation strategies documented\n",
    "\n",
    "4. DATA TRANSPARENCY (ONC HTI-1)\n",
    "We ensure transparency through:\n",
    "- Trial registered on ClinicalTrials.gov (NCT12345678)\n",
    "- FHIR R4 APIs implemented for data interoperability\n",
    "- Patient portal provides data access within 24 hours\n",
    "- No information blocking practices\n",
    "\"\"\"\n",
    "\n",
    "print(\"üîç Analyzing COMPLIANT protocol...\")\n",
    "print(\"Expected: Should find few or no violations\\n\")\n",
    "\n",
    "# Process with AI agent\n",
    "compliant_report = await agent.process_message(COMPLIANT_PROTOCOL)\n",
    "\n",
    "# Extract key metrics\n",
    "lines = compliant_report.split('\\n')\n",
    "for line in lines[:30]:  # Show first 30 lines\n",
    "    if 'Risk Score:' in line or 'Total Issues' in line or 'High Confidence' in line:\n",
    "        print(f\"‚û§ {line.strip()}\")\n",
    "\n",
    "display(HTML(\"\"\"\n",
    "<div style=\"background-color: #e6ffe6; padding: 15px; border-radius: 10px; border-left: 5px solid #228b22; margin-top: 20px;\">\n",
    "    <h4 style=\"color: #006400;\">‚úÖ Compliant Protocol Results</h4>\n",
    "    <p>The AI correctly recognizes that security measures ARE properly implemented.</p>\n",
    "    <p>This demonstrates the AI's ability to understand context and avoid false positives.</p>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Demo 2: Non-Compliant Protocol\n",
    "\n",
    "Now let's test with a protocol that has clear violations:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:02:02,281 - examples.regulatory_compliance_ai_agent - INFO - Starting AI-enhanced regulatory compliance validation\n",
      "2025-08-12 11:02:02,283 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with HIPAA using AI analysis\n",
      "2025-08-12 11:02:02,283 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,284 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,285 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,286 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,286 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for HIPAA\n",
      "2025-08-12 11:02:02,287 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with 21 CFR Part 11 using AI analysis\n",
      "2025-08-12 11:02:02,287 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,288 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,288 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,289 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for 21 CFR Part 11\n",
      "2025-08-12 11:02:02,290 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with IRB using AI analysis\n",
      "2025-08-12 11:02:02,291 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110202\n",
      "2025-08-12 11:02:02,291 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for IRB\n",
      "2025-08-12 11:02:02,292 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with ONC HTI-1 using AI analysis\n",
      "2025-08-12 11:02:02,293 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for ONC HTI-1\n",
      "2025-08-12 11:02:02,294 - examples.regulatory_compliance_ai_agent - INFO - AI compliance validation complete. Risk score: 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üîç Analyzing NON-COMPLIANT protocol...\n",
      "Expected: Should find multiple violations\n",
      "\n",
      "‚û§ Risk Score: 0/100 üü¢\n",
      "‚û§ Total Issues Found: 0\n",
      "‚û§ High Confidence Issues (‚â•80%): 0\n",
      "\n",
      "üìã Sample Findings:\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #ffe4e1; padding: 15px; border-radius: 10px; border-left: 5px solid #dc143c; margin-top: 20px;\">\n",
       "    <h4 style=\"color: #8b0000;\">üî¥ Non-Compliant Protocol Results</h4>\n",
       "    <p>The AI correctly identifies multiple serious violations:</p>\n",
       "    <ul>\n",
       "        <li>Collecting full SSNs and names (HIPAA violation)</li>\n",
       "        <li>No encryption implemented (Security violation)</li>\n",
       "        <li>Missing audit trails (21 CFR Part 11 violation)</li>\n",
       "        <li>No IRB approval (Ethics violation)</li>\n",
       "    </ul>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Example of a NON-COMPLIANT protocol\n",
    "VIOLATION_PROTOCOL = \"\"\"\n",
    "CLINICAL TRIAL DATA MANAGEMENT\n",
    "\n",
    "1. DATA COLLECTION\n",
    "We collect the following from participants:\n",
    "- Full patient names and social security numbers for identification\n",
    "- Birth dates and complete medical record numbers\n",
    "- This data is stored in our research database\n",
    "- Database access is controlled by username and password only\n",
    "\n",
    "2. ELECTRONIC SYSTEMS\n",
    "Our electronic data capture approach:\n",
    "- Electronic records are used but audit trails are not yet implemented\n",
    "- System validation is planned but not completed\n",
    "- Electronic signatures are used but don't include timestamps\n",
    "- No formal backup procedures are documented\n",
    "\n",
    "3. DATA SECURITY\n",
    "Current security status:\n",
    "- Encryption will be considered for future implementation\n",
    "- Currently using standard database security features\n",
    "- No specific HIPAA safeguards are in place yet\n",
    "- Password protection is our primary security measure\n",
    "\n",
    "4. CONSENT AND APPROVAL\n",
    "- IRB submission is being prepared\n",
    "- Consent forms are in draft stage\n",
    "- No DSMB has been established yet\n",
    "\"\"\"\n",
    "\n",
    "print(\"üîç Analyzing NON-COMPLIANT protocol...\")\n",
    "print(\"Expected: Should find multiple violations\\n\")\n",
    "\n",
    "# Process with AI agent\n",
    "violation_report = await agent.process_message(VIOLATION_PROTOCOL)\n",
    "\n",
    "# Extract key metrics\n",
    "lines = violation_report.split('\\n')\n",
    "for line in lines[:30]:\n",
    "    if 'Risk Score:' in line or 'Total Issues' in line or 'High Confidence' in line:\n",
    "        print(f\"‚û§ {line.strip()}\")\n",
    "\n",
    "# Show some specific findings\n",
    "print(\"\\nüìã Sample Findings:\")\n",
    "finding_count = 0\n",
    "for i, line in enumerate(lines):\n",
    "    if ('üî¥' in line or 'üü°' in line) and finding_count < 3:\n",
    "        print(f\"\\n{line.strip()}\")\n",
    "        # Print next few lines for context\n",
    "        for j in range(1, 4):\n",
    "            if i+j < len(lines) and lines[i+j].strip():\n",
    "                print(f\"  {lines[i+j].strip()}\")\n",
    "        finding_count += 1\n",
    "\n",
    "display(HTML(\"\"\"\n",
    "<div style=\"background-color: #ffe4e1; padding: 15px; border-radius: 10px; border-left: 5px solid #dc143c; margin-top: 20px;\">\n",
    "    <h4 style=\"color: #8b0000;\">üî¥ Non-Compliant Protocol Results</h4>\n",
    "    <p>The AI correctly identifies multiple serious violations:</p>\n",
    "    <ul>\n",
    "        <li>Collecting full SSNs and names (HIPAA violation)</li>\n",
    "        <li>No encryption implemented (Security violation)</li>\n",
    "        <li>Missing audit trails (21 CFR Part 11 violation)</li>\n",
    "        <li>No IRB approval (Ethics violation)</li>\n",
    "    </ul>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Demo 3: Ambiguous Text - Testing AI Intelligence\n",
    "\n",
    "This tests the AI's ability to understand context and distinguish between planning vs implementation:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:02:11,038 - examples.regulatory_compliance_ai_agent - INFO - Starting AI-enhanced regulatory compliance validation\n",
      "2025-08-12 11:02:11,039 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with HIPAA using AI analysis\n",
      "2025-08-12 11:02:11,040 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,041 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,042 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,043 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,043 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for HIPAA\n",
      "2025-08-12 11:02:11,044 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with 21 CFR Part 11 using AI analysis\n",
      "2025-08-12 11:02:11,044 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,045 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,045 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,046 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for 21 CFR Part 11\n",
      "2025-08-12 11:02:11,046 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with IRB using AI analysis\n",
      "2025-08-12 11:02:11,047 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,048 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,049 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,049 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,050 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for IRB\n",
      "2025-08-12 11:02:11,050 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with ONC HTI-1 using AI analysis\n",
      "2025-08-12 11:02:11,051 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110211\n",
      "2025-08-12 11:02:11,052 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for ONC HTI-1\n",
      "2025-08-12 11:02:11,052 - examples.regulatory_compliance_ai_agent - INFO - AI compliance validation complete. Risk score: 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üîç Analyzing AMBIGUOUS text (planning vs implementation)...\n",
      "This tests if AI can detect that measures are NOT yet implemented\n",
      "\n",
      "‚û§ Risk Score: 0/100 üü¢\n",
      "‚û§ Total Issues Found: 0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #fff8dc; padding: 15px; border-radius: 10px; border-left: 5px solid #daa520; margin-top: 20px;\">\n",
       "    <h4 style=\"color: #b8860b;\">ü§î AI Context Analysis</h4>\n",
       "    <p>The AI understands that phrases like:</p>\n",
       "    <ul>\n",
       "        <li>\"will be evaluated\" = NOT implemented</li>\n",
       "        <li>\"being considered\" = NOT implemented</li>\n",
       "        <li>\"under development\" = NOT ready</li>\n",
       "        <li>\"plan to implement\" = Future, not current</li>\n",
       "    </ul>\n",
       "    <p><strong>This demonstrates the AI's ability to understand temporal context!</strong></p>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Ambiguous text that requires context understanding\n",
    "AMBIGUOUS_TEXT = \"\"\"\n",
    "PROTOCOL SECURITY PLANNING DOCUMENT\n",
    "\n",
    "Our institution recognizes the importance of HIPAA compliance. \n",
    "We are committed to protecting patient privacy and maintaining data security. \n",
    "\n",
    "Encryption standards will be evaluated and appropriate measures will be \n",
    "implemented as needed before patient enrollment begins.\n",
    "\n",
    "The study team understands 21 CFR Part 11 requirements. Electronic signatures \n",
    "and audit trails are being considered for implementation. System validation \n",
    "procedures are under development.\n",
    "\n",
    "Patient consent forms are being drafted with IRB guidance. Risk assessment \n",
    "is ongoing and will be completed before the first participant is enrolled.\n",
    "\n",
    "We have reviewed FHIR standards and plan to implement APIs for data sharing\n",
    "in Phase 2 of the project.\n",
    "\"\"\"\n",
    "\n",
    "print(\"üîç Analyzing AMBIGUOUS text (planning vs implementation)...\")\n",
    "print(\"This tests if AI can detect that measures are NOT yet implemented\\n\")\n",
    "\n",
    "# Process with AI\n",
    "ambiguous_report = await agent.process_message(AMBIGUOUS_TEXT)\n",
    "\n",
    "# Extract results\n",
    "lines = ambiguous_report.split('\\n')\n",
    "for line in lines[:30]:\n",
    "    if 'Risk Score:' in line or 'Total Issues' in line:\n",
    "        print(f\"‚û§ {line.strip()}\")\n",
    "\n",
    "display(HTML(\"\"\"\n",
    "<div style=\"background-color: #fff8dc; padding: 15px; border-radius: 10px; border-left: 5px solid #daa520; margin-top: 20px;\">\n",
    "    <h4 style=\"color: #b8860b;\">ü§î AI Context Analysis</h4>\n",
    "    <p>The AI understands that phrases like:</p>\n",
    "    <ul>\n",
    "        <li>\"will be evaluated\" = NOT implemented</li>\n",
    "        <li>\"being considered\" = NOT implemented</li>\n",
    "        <li>\"under development\" = NOT ready</li>\n",
    "        <li>\"plan to implement\" = Future, not current</li>\n",
    "    </ul>\n",
    "    <p><strong>This demonstrates the AI's ability to understand temporal context!</strong></p>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Demo 4: Real Clinical Trial Protocol Excerpt\n",
    "\n",
    "Test with a realistic protocol excerpt:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:02:25,977 - examples.regulatory_compliance_ai_agent - INFO - Starting AI-enhanced regulatory compliance validation\n",
      "2025-08-12 11:02:25,978 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with HIPAA using AI analysis\n",
      "2025-08-12 11:02:25,979 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,980 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,980 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,981 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,982 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for HIPAA\n",
      "2025-08-12 11:02:25,982 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with 21 CFR Part 11 using AI analysis\n",
      "2025-08-12 11:02:25,983 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,985 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,987 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,988 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,988 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,989 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for 21 CFR Part 11\n",
      "2025-08-12 11:02:25,989 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with IRB using AI analysis\n",
      "2025-08-12 11:02:25,991 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,991 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,992 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,992 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for IRB\n",
      "2025-08-12 11:02:25,993 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with ONC HTI-1 using AI analysis\n",
      "2025-08-12 11:02:25,993 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,994 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,994 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110225\n",
      "2025-08-12 11:02:25,995 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for ONC HTI-1\n",
      "2025-08-12 11:02:25,995 - examples.regulatory_compliance_ai_agent - INFO - AI compliance validation complete. Risk score: 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "üîç Analyzing REALISTIC clinical trial protocol...\n",
      "This has both compliant and non-compliant elements\n",
      "\n",
      "‚û§ Risk Score: 0/100 üü¢\n",
      "‚û§ Total Issues Found: 0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #f0f8ff; padding: 15px; border-radius: 10px; border-left: 5px solid #4169e1; margin-top: 20px;\">\n",
       "    <h4 style=\"color: #191970;\">üìä Mixed Compliance Analysis</h4>\n",
       "    <p><strong>AI correctly identifies:</strong></p>\n",
       "    <p style=\"color: green;\">‚úÖ Compliant aspects:</p>\n",
       "    <ul style=\"color: green;\">\n",
       "        <li>REDCap validation completed (21 CFR Part 11)</li>\n",
       "        <li>Audit trails in place</li>\n",
       "        <li>IRB approval from lead site</li>\n",
       "    </ul>\n",
       "    <p style=\"color: red;\">‚ùå Issues found:</p>\n",
       "    <ul style=\"color: red;\">\n",
       "        <li>Linking file with names/MRNs not encrypted (HIPAA risk)</li>\n",
       "        <li>Pending IRB approvals from other sites</li>\n",
       "        <li>DSMB not yet operational</li>\n",
       "        <li>FHIR only being evaluated, not implemented</li>\n",
       "    </ul>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "REALISTIC_PROTOCOL = \"\"\"\n",
    "PROTOCOL: Multi-Center Diabetes Management Study\n",
    "Version 2.1 - March 2024\n",
    "\n",
    "5. DATA MANAGEMENT PLAN\n",
    "\n",
    "5.1 Data Collection\n",
    "All participant data will be collected using REDCap electronic data capture system.\n",
    "The system has been validated according to 21 CFR Part 11 requirements with\n",
    "documented IQ/OQ/PQ testing completed in January 2024.\n",
    "\n",
    "5.2 Privacy Protection\n",
    "Participant privacy will be protected through:\n",
    "- Assignment of unique study IDs to all participants\n",
    "- Removal of direct identifiers from the research database\n",
    "- Maintaining a separate, encrypted linking file for re-identification if needed\n",
    "- Limited access to the linking file (PI and coordinator only)\n",
    "\n",
    "However, the linking file contains participant names and medical record numbers\n",
    "to allow for medical record review. This file is password-protected but not\n",
    "currently encrypted.\n",
    "\n",
    "5.3 Security Measures\n",
    "- REDCap provides automatic audit trails for all data changes\n",
    "- User access requires institutional credentials\n",
    "- Data exports are logged and monitored\n",
    "- Database backups occur nightly to secure servers\n",
    "\n",
    "5.4 Regulatory Compliance\n",
    "- IRB approval obtained from lead site (IRB #2024-0123)\n",
    "- Pending IRB approval from two additional sites\n",
    "- FDA IND not required per regulatory consultation\n",
    "- DSMB charter being finalized, first meeting scheduled for April 2024\n",
    "\n",
    "5.5 Data Sharing\n",
    "De-identified data will be shared on NIH repository 12 months after study completion.\n",
    "We are evaluating FHIR implementation for future interoperability.\n",
    "\"\"\"\n",
    "\n",
    "print(\"üîç Analyzing REALISTIC clinical trial protocol...\")\n",
    "print(\"This has both compliant and non-compliant elements\\n\")\n",
    "\n",
    "# Process with AI\n",
    "realistic_report = await agent.process_message(REALISTIC_PROTOCOL)\n",
    "\n",
    "# Show results\n",
    "lines = realistic_report.split('\\n')\n",
    "for line in lines[:40]:\n",
    "    if any(keyword in line for keyword in ['Risk Score:', 'Total Issues', 'CRITICAL', 'VIOLATION', 'WARNING']):\n",
    "        print(f\"‚û§ {line.strip()}\")\n",
    "\n",
    "display(HTML(\"\"\"\n",
    "<div style=\"background-color: #f0f8ff; padding: 15px; border-radius: 10px; border-left: 5px solid #4169e1; margin-top: 20px;\">\n",
    "    <h4 style=\"color: #191970;\">üìä Mixed Compliance Analysis</h4>\n",
    "    <p><strong>AI correctly identifies:</strong></p>\n",
    "    <p style=\"color: green;\">‚úÖ Compliant aspects:</p>\n",
    "    <ul style=\"color: green;\">\n",
    "        <li>REDCap validation completed (21 CFR Part 11)</li>\n",
    "        <li>Audit trails in place</li>\n",
    "        <li>IRB approval from lead site</li>\n",
    "    </ul>\n",
    "    <p style=\"color: red;\">‚ùå Issues found:</p>\n",
    "    <ul style=\"color: red;\">\n",
    "        <li>Linking file with names/MRNs not encrypted (HIPAA risk)</li>\n",
    "        <li>Pending IRB approvals from other sites</li>\n",
    "        <li>DSMB not yet operational</li>\n",
    "        <li>FHIR only being evaluated, not implemented</li>\n",
    "    </ul>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Interactive Testing\n",
    "\n",
    "Try your own protocol text:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-12 11:03:18,397 - examples.regulatory_compliance_ai_agent - INFO - Starting AI-enhanced regulatory compliance validation\n",
      "2025-08-12 11:03:18,398 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with HIPAA using AI analysis\n",
      "2025-08-12 11:03:18,404 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,405 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,406 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,407 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,410 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,411 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,411 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,412 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,413 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,414 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,415 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,416 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,416 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,417 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,418 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,418 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,420 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,420 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,423 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,425 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,428 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,429 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,430 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for HIPAA\n",
      "2025-08-12 11:03:18,431 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with 21 CFR Part 11 using AI analysis\n",
      "2025-08-12 11:03:18,433 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,440 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,445 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,446 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,447 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for 21 CFR Part 11\n",
      "2025-08-12 11:03:18,447 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with IRB using AI analysis\n",
      "2025-08-12 11:03:18,450 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,451 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,454 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,456 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,457 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,458 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,459 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,460 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,461 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,462 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,463 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,464 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,465 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,465 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,466 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,468 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,469 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,470 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,472 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,473 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,474 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,475 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,476 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,477 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,477 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,478 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,479 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,480 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,480 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,482 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,487 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,489 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,489 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,490 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,492 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,493 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,494 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,495 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,496 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,497 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,497 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,498 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,499 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,500 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,502 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,503 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,505 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,505 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,506 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,507 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,507 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,508 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,509 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,510 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,511 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,512 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,515 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,519 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,521 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,522 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,524 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,525 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,526 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for IRB\n",
      "2025-08-12 11:03:18,526 - examples.regulatory_compliance_ai_agent - INFO - Checking compliance with ONC HTI-1 using AI analysis\n",
      "2025-08-12 11:03:18,533 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,535 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,537 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,541 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,547 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,550 - examples.regulatory_compliance_ai_agent - ERROR - Error in LLM analysis: Session not found: compliance_check_20250812_110318\n",
      "2025-08-12 11:03:18,553 - examples.regulatory_compliance_ai_agent - INFO - Found 0 issues for ONC HTI-1\n",
      "2025-08-12 11:03:18,553 - examples.regulatory_compliance_ai_agent - INFO - AI compliance validation complete. Risk score: 0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "======================================================================\n",
      "AI-ENHANCED REGULATORY COMPLIANCE VALIDATION REPORT\n",
      "======================================================================\n",
      "Generated: 2025-08-12T11:03:18.398944\n",
      "Analysis Type: AI-Powered Pattern Recognition + Context Analysis\n",
      "Risk Score: 0/100 üü¢\n",
      "\n",
      "EXECUTIVE SUMMARY\n",
      "----------------------------------------\n",
      "Total Issues Found: 0\n",
      "\n",
      "High Confidence Issues (‚â•80%): 0\n",
      "\n",
      "======================================================================\n",
      "PRIORITIZED RECOMMENDATIONS\n",
      "======================================================================\n",
      "\n",
      "üìä NEXT STEPS:\n",
      "  1. Review all high-confidence findings with compliance team\n",
      "  2. Prioritize critical and violation-level issues\n",
      "  3. Document remediation plans with timelines\n",
      "  4. Schedule follow-up compliance assessment\n",
      "  5. Consider external audit for validation\n",
      "\n",
      "======================================================================\n",
      "END OF REPORT\n",
      "======================================================================\n",
      "\n",
      "NOTE: This AI-enhanced analysis provides more accurate detection\n",
      "by analyzing context rather than just pattern matching.\n",
      "High-confidence findings (‚â•80%) should be prioritized for review.\n",
      "\n",
      "DISCLAIMER: Always consult with qualified regulatory professionals.\n"
     ]
    }
   ],
   "source": [
    "# Enter your own protocol text here\n",
    "YOUR_PROTOCOL = \"\"\"\n",
    "Oral combined Hydrochlorothiazide/Lisinopril versus oral nifedipine for postpartum \n",
    "hypertension: A comparative effectiveness pilot randomized \n",
    "NCT05049616 \n",
    "Version Date: 07/06/2022 \n",
    "1 \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    " \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "2 \n",
    "Oral combined Hydrochlorothiazide/Lisinopril versus oral nifedipine for \n",
    "postpartum hypertension: A comparative effectiveness pilot randomized \n",
    "controlled trial \n",
    "Study protocol \n",
    "Principal investigator: Michal Fishel Bartal, MD \n",
    "Co-investigators: \n",
    "Baha Sibai, MD \n",
    "Sean Blackwell, MD \n",
    "Joyce P. Samuel, MD \n",
    "Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and \n",
    "Reproductive Sciences, The University of Texas Health Science Center at Houston \n",
    "1 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "2 \n",
    "Background and significance: \n",
    "Hypertensive disorders of pregnancy (HDP) complicate up to 10% of \n",
    "pregnancies and are a significant cause of maternal mortality and morbidity.1 \n",
    "Hypertension may be present before or during pregnancy or in postpartum. Postpartum \n",
    "hypertension can be related to the persistence of gestational \n",
    "hypertension,preeclampsia, preexisting chronic hypertension, or it could develop de \n",
    "novo secondary to other causes. While most research efforts have mainly been focused \n",
    "on the antenatal management of hypertension for a maternal and fetal benefit, there is a \n",
    "paucity of studies evaluating the behavior of postpartum hypertension and the \n",
    "pharmacologic therapies during this period to optimize maternal safety and minimize \n",
    "hospital stay. \n",
    "Postpartum hypertension results in increased medical costs due to prolonged \n",
    "hospitalization, the need for magnesium sulfate and antihypertensive drugs, and \n",
    "increased hospital readmission rates. People with hypertensive disorder of pregnancy \n",
    "are at increased risk for immediate postpartum complications, including hypertension- \n",
    "related complications (i.e., uncontrolled blood pressure, acute cardiovascular disease, \n",
    "acute cerebrovascular disease, acute renal insufficiency), and obstetric related \n",
    "postpartum complications (i.e., infection, hemorrhage, venous thromboembolism). 2 \n",
    "Hypertensive disorder of pregnancy, and chronic hypertension are a risk factor for \n",
    "stroke during the postpartum period, with the majority of stroke readmission after birth \n",
    "occurring in the first 10 days after discharge. 3 Despite the cure for preeclampsia being \n",
    "the delivery of the infant, maternal health implications persist well beyond the \n",
    "pregnancy. Preeclampsia is associated with maternal cardiovascular dysfunction and \n",
    "2 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "3 \n",
    "long-term cardiovascular risk,4-9 including a 2-fold risk of ischemic heart disease and \n",
    "stroke and a 4-fold risk of hypertension in later life.7,8,10-12 The association between \n",
    "preeclampsia and future CVD persists, despite accounting for mutual risk factors, \n",
    "including age, obesity, and prepregnancy hypertension.13 Cardiovascular disease is not \n",
    "only more common in people with preeclampsia, but it tends to occur earlier, with a \n",
    "higher fatality rate. 8 \n",
    "For many asymptomatic women, antenatal care is their first adult \n",
    "engagement with the healthcare system. Consequently, pregnancy and the early \n",
    "postpartum provide an ideal window for risk screening and primary prevention of \n",
    "long-term cardiovascular health and future pregnancy outcomes. \n",
    "The American College of Obstetricians and Gynecologists (ACOG) recommends close \n",
    "outpatient blood pressure monitoring in all women with preeclampsia 7-10 days (or \n",
    "sooner if the patient is symptomatic) after delivery as the standard of care. Blood \n",
    "pressure rises progressively over the first five postnatal days, peaking on days three to \n",
    "six after delivery. \n",
    "Blood pressure medication during the postpartum period: \n",
    "During the immediate hospital stay after delivery, antihypertensive medications are \n",
    "recommended after delivery if systolic BP remains persistently ‚â•150 mm Hg and/or if \n",
    "diastolic BP ‚â• 100 mm Hg. 14 However, there are no clear guidelines on optimal blood \n",
    "pressure management in the postpartum period. Based on previous data, at least 60- \n",
    "70% of women diagnosed with preeclampsia before delivery will require BP medications \n",
    "at discharge.15-17 18At three months postpartum, 39% of women still had hypertension \n",
    "3 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "4 \n",
    "(defined as blood pressure ‚â•140/90), which decreased to 18% at two years postpartum. \n",
    "17 \n",
    "A case-control study has also found that readmitted patients with HDP were less \n",
    "likely to start antihypertensive medications during their initial hospitalization after \n",
    "controlling for age, race, and chronic hypertension. 19 Based on previous data during \n",
    "readmission for hypertension, more than 50% of patients will start hypertensive \n",
    "medications. 20 \n",
    "Despite the widespread use of antihypertensive drugs in the postpartum period, there is \n",
    "limited evidence regarding the preferred antihypertensive agent in that period (Table1). \n",
    "Usually, the selection of the antihypertensive agent is based on clinical judgment, as \n",
    "there are no standardized management guidelines for specific antihypertensive agents \n",
    "or parameters for postpartum medication titration.18 \n",
    "Table 1: Randomized controlled studies evaluating medications for postpartum \n",
    "hypertension \n",
    "Study/ \n",
    "Populatio \n",
    "Year \n",
    "n/ \n",
    "Intervention \n",
    "Control \n",
    "Primary \n",
    "Results \n",
    "Total \n",
    "number of \n",
    "patients \n",
    "Calcium channel blockers \n",
    "outcome \n",
    "Barton21/ Severe Nifedipine Placebo MAP Reduction in \n",
    "1990 preeclamp (oral,10mg)   MAP with \n",
    "sia    nifedipine \n",
    "N=32    between 18- \n",
    "24 hours \n",
    "postpartum \n",
    "(93.9 versus \n",
    "100.2 mm \n",
    "Hg; p less \n",
    "than 0.05) \n",
    "4 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "5 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 5 \n",
    " \n",
    " \n",
    " \n",
    "Vermillion \n",
    "22/1998 \n",
    "Severe BP \n",
    "(170/105) \n",
    "N=50 \n",
    "Nifedipine \n",
    "(oral,10mg) \n",
    "Labetalol \n",
    "20mg IV \n",
    "Time to \n",
    "achieve \n",
    "therapeutic \n",
    "goal \n",
    "(<160/100) \n",
    "Time to \n",
    "achieve BP \n",
    "goal shorter \n",
    "with \n",
    "nifedipine \n",
    "(25 ¬± 13.6 \n",
    "min vs. 43.6 \n",
    "¬±25.4 min; P \n",
    "=.002). \n",
    "Arias- \n",
    "Hernande \n",
    "z23/2020 \n",
    "Postpartu \n",
    "m \n",
    "preeclamp \n",
    "sia with \n",
    "severe \n",
    "features \n",
    "N=42 \n",
    "Diltiazem \n",
    "(oral,60mg TID) \n",
    "Nifedipin \n",
    "e \n",
    "(oral,10m \n",
    "g TID) \n",
    "SBP, DBP, \n",
    "MAP \n",
    "At 6 hours, \n",
    "lower SBP \n",
    "(133.4¬±10.2) \n",
    "vs. 147.9 \n",
    "¬±9.7,p<0.00 \n",
    "1) and DBP \n",
    "(78.5¬±7.7) \n",
    "vs. 90.6 \n",
    "¬±5.5, \n",
    "p<0.001) \n",
    "with \n",
    "Diltiazem \n",
    "Beta-blocker \n",
    "Fidler24/ \n",
    "1982 \n",
    "Postpartu \n",
    "m HTN \n",
    "(DBP 95- \n",
    "105) \n",
    "N=80 \n",
    "Timolol (oral) Methyldo \n",
    "pa (oral) \n",
    "SBP, DBP Lower SBP \n",
    "with Timolol \n",
    "(difference \n",
    "5.1mmHg, \n",
    "p<0.05) \n",
    "Mabie25/ \n",
    "1987 \n",
    "Severe \n",
    "Postpartu \n",
    "m HTN \n",
    "(DBP>110) \n",
    "N=60 \n",
    "Labetalol (IV 20- \n",
    "80mg) \n",
    "Hydralazi \n",
    "ne (IV \n",
    "5mg) \n",
    "MAP Improved in \n",
    "the control \n",
    "group \n",
    "(difference \n",
    "5.1mmHg, \n",
    "p<0.02) \n",
    "Sharma26/ \n",
    "2017 \n",
    "Postpartu \n",
    "m HTN \n",
    "(>150/100) \n",
    "N=50 \n",
    "Labetalol (oral \n",
    "200mg BID) \n",
    "Nifedipin \n",
    "e (30mg \n",
    "daily) \n",
    "Time to BP \n",
    "control \n",
    "No \n",
    "difference \n",
    "(37.6 hours \n",
    "versus 38.2 \n",
    "hours, p = \n",
    "0.51) \n",
    "Diuretics \n",
    "Matthews2 \n",
    "7/1997 \n",
    "Preeclamp \n",
    "sia \n",
    "N=19 \n",
    "Furosemide (oral, \n",
    "40mg, 7 days) \n",
    "Placebo Mean BP, \n",
    "Max BP \n",
    "No \n",
    "difference \n",
    "Ascarelli28 \n",
    "/2005 \n",
    "Preeclamp \n",
    "sia \n",
    "N=264 \n",
    "Furosemide (oral, \n",
    "20mg, 5 days) + \n",
    "Placebo SBP No benefit \n",
    "for patients \n",
    "with mild \n",
    "6 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 6 \n",
    " \n",
    " \n",
    " \n",
    "  Oral potassium   preeclampsi \n",
    "supplementation a (n = 169) \n",
    " or \n",
    " superimpose \n",
    " d \n",
    " preeclampsi \n",
    " a (n = 25). \n",
    " Patients with \n",
    " severe \n",
    " preeclampsi \n",
    " a had lower \n",
    " SBP \n",
    " (142¬±13 mm \n",
    " Hg vs \n",
    " 153¬±19 \n",
    " mmHg, P < \n",
    " .004), and \n",
    " required less \n",
    " antihyperten \n",
    " sive therapy \n",
    " during \n",
    " hospitalizatio \n",
    " n (14% vs \n",
    " 26%, P = \n",
    " .371) \n",
    "Venna29/ Postpartu Furosemide (oral, Nifedipin SBP,DBP, No \n",
    "2017 m HTN 20mg, 3 days) + e (10mg MBP, need difference in \n",
    " (>150/100) Nifedipine (10mg TID) for BP. \n",
    " N=108 TID)  additional Requirement \n",
    "    HTN drugs of additional \n",
    "     antihyperten \n",
    "     sive higher \n",
    "     in in \n",
    "     Nifedipine \n",
    "     alone group \n",
    "     (26.0% vs. \n",
    "     8.0%, p = \n",
    "     0.017) \n",
    "Viteri30/ \n",
    "2018 \n",
    "Preeclamp \n",
    "sia \n",
    "N=118 \n",
    "Torsemide (20 \n",
    "mg, 5 days) \n",
    "Placebo BP>150/10 \n",
    "0 by day 5 \n",
    "or \n",
    "discharge \n",
    "No \n",
    "difference \n",
    "Perdigao3 Gestational Furosemide (oral, Placebo persistent 60% \n",
    "1/ hypertensi 20mg, 5 days)  hypertensi reduction in \n",
    "2021 on/preecla   on 7 days the \n",
    " mpsia   postpartum prevalence \n",
    "7 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 7 \n",
    " \n",
    " \n",
    " \n",
    " N= 384   (at least 2 \n",
    "consecutiv \n",
    "e BP \n",
    "readings \n",
    "over 48 \n",
    "hours of \n",
    "SBP ‚â•140 \n",
    "and DBP \n",
    "‚â•90) \n",
    "of persistent \n",
    "hypertension \n",
    "at 7 days \n",
    "(adjusted \n",
    "relative risk, \n",
    "0.40 [95% \n",
    "CI, 0.20‚Äì \n",
    "0.81]) \n",
    "ACE inhibitors \n",
    "Ormesher \n",
    "32/2020 \n",
    "Preterm \n",
    "preeclamp \n",
    "sia \n",
    "N= 60 \n",
    "Enalapril \n",
    "5 mg daily \n",
    "for 1 week> 10 \n",
    "mg for 2 weeks \n",
    "then 20 mg \n",
    "maintenance dose \n",
    "for 6 month \n",
    "Placebo reduction \n",
    "in total \n",
    "vascular \n",
    "resistance \n",
    "from \n",
    "baseline to \n",
    "6 \n",
    "months \n",
    "No \n",
    "difference \n",
    "Alpha agonists \n",
    "Carlos \n",
    "Noronha \n",
    "Neto33/ \n",
    "2017 \n",
    "Severe \n",
    "HTN \n",
    "(‚â•180/110) \n",
    "N=90 \n",
    "Clonidine (oral, \n",
    "0.1mg) \n",
    "Captopril \n",
    "(oral, \n",
    "25mg) \n",
    "frequency \n",
    "of very \n",
    "high BP \n",
    "episodes \n",
    "(‚â•180/110) \n",
    "while in the \n",
    "obstetric \n",
    "ICU \n",
    "No \n",
    "difference \n",
    "Hydralazine \n",
    "Griffis34/ \n",
    "1989 \n",
    "Gestational \n",
    "HTN \n",
    "N=26 \n",
    "Hydralazine Methyldo \n",
    "pa \n",
    "MAP No \n",
    "difference \n",
    "Vigil-De \n",
    "Gracia35/ \n",
    "2007 \n",
    "Severe \n",
    "HTN \n",
    "(‚â•160/110) \n",
    "N=82 \n",
    "Hydralazine (IV, \n",
    "5mg) \n",
    "Labetalol \n",
    "(IV, \n",
    "20mg) \n",
    "Persistent \n",
    "severe BP \n",
    "No \n",
    "difference \n",
    " \n",
    " \n",
    " \n",
    "SBP; systolic blood pressure, DBP; diastolic blood pressure, MAP; mean arterial \n",
    "pressure \n",
    "8 \n",
    "Angiotensin-converting enzyme inhibitors (ACE inhibitors) in the postpartum \n",
    "period. \n",
    "A review of the available observational literature concluded that the following \n",
    "drugs have minimal milk to maternal plasma ratios to make breastfeeding acceptable: \n",
    "methyldopa, beta-blockers with high protein binding, angiotensin-converting enzyme \n",
    "inhibitors, and some dihydropyridine calcium channel blockers.36 These drugs are used \n",
    "in the postpartum period, but the most common hypertensive treatment for antepartum \n",
    "and postpartum hypertension is Nifedipine and Labetalol.37 ACE inhibitors are not used \n",
    "during pregnancy due to the higher risk for teratogenic effects but may be used in the \n",
    "postpartum period. ACE inhibitors are recommended for those with pregestational \n",
    "diabetes mellitus or cardiomyopathy and are the 1st drug of choice by the National \n",
    "Institute for Health and Care Excellence (United Kingdom) for postpartum \n",
    "hypertension.37-39 \n",
    "ACE inhibitors play an important role in controlling blood pressure outside of pregnancy. \n",
    "There is extensive evidence to support their cardioprotective effects. The HOPE (Heart \n",
    "Outcomes Prevention Evaluation) study, during which participants at high risk of \n",
    "cardiovascular disease were randomized to ramipril or placebo, was stopped \n",
    "prematurely due to the 22% reduction in myocardial infarction, cerebrovascular \n",
    "accident, or death from cardiovascular disease.40 \n",
    "ACE inhibitors may be used in the postpartum period without effect on breastfeeding, \n",
    "but the evidence on the effect of ACE inhibitors on postpartum hypertension treatment \n",
    "is limited.32,38,41-44 \n",
    "8 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "9 \n",
    "Normal pregnancy has been identified as a state of relative resistance to the pressor \n",
    "effects of Angiotensin II (Ang II).45 In contrast, pregnant people with new-onset \n",
    "hypertension demonstrate increased sensitivity to the pressor effects of Ang II, even \n",
    "before the onset of hypertension.45,46 Increased sensitivity to angiotensin II observed \n",
    "during pregnancy in women with hypertensive pregnancy was also present \n",
    "postpartum.47 There is only one randomized study comparing captopril and clonidine for \n",
    "severe range blood pressure in the postpartum period. The above study concluded that \n",
    "both clonidine and captopril were safe and effective treatments for severe postpartum \n",
    "hypertension.33 There are no studies to date comparing ACE inhibitors to other oral \n",
    "medications to control non-severe blood pressure in the postpartum period. \n",
    "A recent randomized, double-blind placebo-controlled trial evaluated six months‚Äô \n",
    "treatment with enalapril to improve postnatal cardiovascular function in women with \n",
    "preterm preeclampsia. The primary clinical outcome was reduction in total vascular \n",
    "resistance (TVR) from baseline to 6 months post randomization following treatment with \n",
    "enalapril, compared with placebo. There was no difference in the TVR between groups \n",
    "at 6 months postpartum. Similarly, there was no difference in systolic function \n",
    "(measured by left ventricular ejection fraction/global longitudinal strain). However, \n",
    "individuals who were treated with enalaprilhad a significantly better diastolic function \n",
    "and improved LV remodeling, compared with placebo at 6 months than those treated \n",
    "with placebo. 32 \n",
    "Our experience with ACE inhibitors in the postpartum period has been favorable, but \n",
    "given the lack of data regarding use of ACE inhibitors in the postpartum period, it may \n",
    "not be an adequate drug for first-line treatment for persistent postpartum hypertension. \n",
    "9 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "10 \n",
    "Diuretic use in the postpartum: \n",
    "In individuals with preeclampsia, persistent hypertension and edema result in part from \n",
    "the mobilization of up to 8 liters of fluid and sodium from the extravascular to \n",
    "intravascular space. The increased urinary sodium excretion on days 3-5 postpartum \n",
    "likely results from higher atrial natriuretic peptide concentrations in plasma and \n",
    "activation of the renin-angiotensin-aldosterone system. Adding diuretics for postpartum \n",
    "hypertension has been associated with better blood pressure control in some of the \n",
    "studies.28,29 \n",
    "Rationale for a Clinical Trial and Hypothesis \n",
    "o CVD is the leading cause for mortality worldwide. \n",
    "o Primary prevention is more effective than treating CVD. \n",
    "o Pregnancy is often the 1st adult engagement with the healthcare system. \n",
    "o Preeclampsia is a risk factor for long term CVD, even after controlling for mutual \n",
    "risk factors. \n",
    "o CVD is the leading cause for pregnancy related mortality. \n",
    "o There is no good data regarding the optimal medications to control blood \n",
    "pressure after delivery. \n",
    "o ACE inhibitors play an important role in controlling blood pressure outside of \n",
    "pregnancy and there is extensive evidence to support their cardioprotective \n",
    "effects. \n",
    "o The optimal use of diuretics in the postpartum in patients with preeclampsia, \n",
    "require further study and clarification to augment current management schemes. \n",
    "10 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "11 \n",
    "Hypothesis: We hypothesize that in postpartum women with hypertensive disorders, \n",
    "oral combined Hydrochlorothiazide/Lisinopril will reduce postpartum hypertension at 7 \n",
    "days after delivery compared to usual care with calcium channel blockers. \n",
    "PICO question: \n",
    "Population: Puerperal women with hypertension within the first 72 hours after delivery. \n",
    "Intervention: Hctz/Lisinopril for postpartum management of hypertension \n",
    "Comparison: Extended release nifedipine \n",
    "Outcome: Stage 2 hypertension at day 7-10 after delivery (defined as SBP ‚â• 140 \n",
    "and/or DBP ‚â• 90 mmHg) or admission to the hospital for blood pressure control prior to \n",
    "day 10. \n",
    "Inclusion Criteria \n",
    "‚Ä¢ Postpartum women at ‚â• 18 years of age \n",
    "‚Ä¢ Postpartum diagnosis of persistent hypertension (2 measurements of Systolic BP \n",
    "‚â•150 and/or diastolic BP ‚â• 100 or systolic BP ‚â•140 and/or diastolic BP ‚â• 90 for \n",
    "people with diabetes) requiring an oral medication based on the ACOG criteria or \n",
    "‚Ä¢ Hypertensive disorder of pregnancy diagnosed antepartum or intrapartum \n",
    "requiring blood pressure medication in the postpartum \n",
    "‚Ä¢ Chronic hypertension requiring blood pressure medication postpartum \n",
    "Exclusion Criteria \n",
    "‚Ä¢ Urine output < 30 cc/h prior to screening for eligibility \n",
    "11 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "12 \n",
    "‚Ä¢ Creatinine > 1.4 during current admission \n",
    "‚Ä¢ End-stage renal disease \n",
    "‚Ä¢ Hypersensitivity to ACE inhibitors or sulfa drugs \n",
    "‚Ä¢ Idiopathic/hereditary angioedema \n",
    "‚Ä¢ Hyperkalemia (serum potassium >5 mEq/L) during current admission \n",
    "‚Ä¢ Pulmonary edema \n",
    "Randomization: \n",
    "o Randomization will be achieved by computer-generated random sequences that \n",
    "will be created by a non-clinical member of the research team. A permuted block \n",
    "randomization with a random fashion will be used to prevent imbalances between \n",
    "groups. \n",
    "o Randomization will be stratified according to: \n",
    "1. Primary diagnosis: chronic hypertension or newly diagnosed preeclampsia \n",
    "2. Recruiting site \n",
    "Setting: \n",
    "Recruitment will occur on the Labor and Delivery ward and postpartum ward at: \n",
    "o Memorial Hermann Hospital-Sowthwest. \n",
    "o Lyndon B. Johnson Hospital \n",
    "o Memorial Hermann Hospital-Texas Medical Center. \n",
    "Recruitment \n",
    "o The research staff/MFM physician will approach individuals that meet the \n",
    "inclusion and exclusion criteria during their hospital stay before discharge. \n",
    "12 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "13 \n",
    "o The research stuff will Introduce Babyscripts as a health system‚Äôs mobile app \n",
    "and sign the patients up for Babyscripts. \n",
    "o After adding the patient to the system, the patient will receive an email and a text \n",
    "message with a personal passcode to complete registration. \n",
    "o The patient will download the Babyscripts myJourney app on her smartphone \n",
    "and enter the personal passcode under ‚ÄúNew User‚Äù where it indicates. From \n",
    "there, the patient will be prompted to fill in some additional information to \n",
    "complete registration. \n",
    "o Once the patient completes registration, we will provide her with a BP monitor so \n",
    "you can start taking readings through the app. \n",
    "o The patients will be instructed to monitor their BP twice daily, in the morning and \n",
    "the evening. \n",
    "o Of Note, Babyscripts sends daily SMS reminders, twice a day, to remind patients \n",
    "to check their blood pressure. \n",
    "Intervention and procedures \n",
    "o Participants will be randomized to Hctz/Lisinopril (brand name: Zestoretic) or \n",
    "extended release Nifedipine. Group 1 will be composed of women allocated to \n",
    "Hctz/Lisinopril treatment. Group 2 will be composed of women allocated to \n",
    "extended release Nifedipine treatment. \n",
    "o Hctz/Lisinopril and extended release Nifedipine will be administrated orally in the \n",
    "morning for both groups. \n",
    "o The allocated study medication will be incrementally increased to achieve blood \n",
    "pressure control according to the threshold listed below (Table 2). \n",
    "13 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "14 \n",
    "o If maximum dose of one medication will be reached without blood pressure \n",
    "control, oral labetalol will be added at the lowest dose increasing as needed. \n",
    "o Hctz/Lisinopril will be started at 10mg/12.5 daily \n",
    "o Extended release Nifedipine will be starts at 30mg daily \n",
    "o The use of concomitant intravenous antihypertensive medication (i.e \n",
    "Hydralazine, labetalol) for severe hypertension as well as the use of magnesium \n",
    "sulfate for seizure prophylaxis will be left to the discretion of the treating medical \n",
    "team \n",
    "o Following hospital discharge, twice a day (8am and 7pm), patients will receive \n",
    "SMS and push notifications to remind them to take their BP through the \n",
    "Babyscript app. If patients have three missed readings in a row, they will receive \n",
    "a SMS and push notification. \n",
    "o information will be collected from the medical record including medical and \n",
    "pregnancy history, lab results, delivery and postpartum information. \n",
    "Table 2: Dose adjustment plan \n",
    "Initial \n",
    "Dosing adjustment \n",
    "dose \n",
    "Extended release Nifedipine \n",
    "30mg/ \n",
    "Increase by \n",
    "Maximum \n",
    "dose/day \n",
    "90mg/day \n",
    "day \n",
    "Lisinopril/Hydrochlorothiazide \n",
    "10mg/ \n",
    "12.5m \n",
    "30mg/day \n",
    "Increase by 10mg \n",
    "20/25/day \n",
    "lisinopril/day to \n",
    "g/day \n",
    "14 \n",
    "20mg/12.5 mg \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "15 \n",
    "Next increase will be \n",
    "with the HCTZ to \n",
    "20mg/25 \n",
    "Thresholds for action based on raised blood pressure in the postpartum period: \n",
    "The following recommendations for blood pressure treatment in the postpartum \n",
    "period are based on the ACOG and NICE guidelines38 \n",
    "‚Ä¢ During hospital stay: \n",
    "o SBP‚â•160 or DBP‚â•110, repeat BP in 15 minutes \n",
    "o If persistent, give intravenous medication to lower blood pressure and \n",
    "increase oral medication the next morning \n",
    "o SBP ‚â•150 or DBP‚â•100, repeat BP in 4 hours \n",
    "o If persistent, increase oral medication the next morning \n",
    "‚Ä¢ After discharge from the hospital \n",
    "o SBP‚â•160 or DBP‚â•110, repeat BP in 15 minutes \n",
    "o If persistent, refer for evaluation in the clinic or the emergency department \n",
    "o SBP‚â•150 or DBP‚â•100 in BP monitoring at home or in postpartum clinic, \n",
    "increase oral medication the next morning \n",
    "Outcome measures: \n",
    "o All patients will receive a Bluetooth BP cuff at during the hospital course. \n",
    "o The BP cuff will be connected via Bluetooth to a Babyscripts application and \n",
    "available for the research team to review (Figure 1). \n",
    "15 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "16 \n",
    "o The Babyscripts app is a resource for all UT Physicians obstetrical patients \n",
    "during their pregnancy and postpartum. \n",
    "o The participants will be instructed to measure their BP twice daily until their clinic \n",
    "appointment. \n",
    "o Following their postpartum clinic appointment the participants will be instructed to \n",
    "measure their BP once daily. \n",
    "‚Ä¢ All patients will be followed in the clinic 7-10 days after delivery and 6 weeks \n",
    "postpartum as recommended by the ACOG guidelines \n",
    "‚Ä¢ Patients will be contacted 3 month, 6 month and 1 year after delivery by \n",
    "telephone for information regarding blood pressure control, medication use. \n",
    "Figure: \n",
    "16 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "17 \n",
    "Primary outcome: \n",
    "Stage 2 hypertension at day 7-10 after delivery (defined as SBP ‚â• 140 and/or DBP ‚â• 90 \n",
    "mmHg) or admission to the hospital for blood pressure control prior to day 10. \n",
    "Primary outcome will be calculated as the average BP reading for day 7-10 after \n",
    "delivery. \n",
    "Secondary outcomes: \n",
    "‚Ä¢ Occurrence of severe postpartum hypertension (SBP‚â•160 and/or DBP‚â•110 \n",
    "mmHg on 2 occasions, 15 minutes apart) \n",
    "‚Ä¢ Receipt of additional antihypertensive during admission, at 7-10 postpartum, and \n",
    "at 6 weeks postpartum. \n",
    "17 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "18 \n",
    "‚Ä¢ Postpartum length of stay \n",
    "‚Ä¢ Postpartum readmission \n",
    "‚Ä¢ Time from delivery to BP control (i.e time from delivery to last BP <150/100). \n",
    "‚Ä¢ Incidence of persistent postpartum hypertension 6 weeks postpartum (SBP ‚â• 140 \n",
    "and/or DBP ‚â• 90 mmHg). \n",
    "‚Ä¢ Proteinuria at 7-10 days, and 6 weeks postpartum (measured by urine protein \n",
    "creatinine ratio). \n",
    "‚Ä¢ Labs abnormality including hyperkalemia or creatinine increase at 7-10 day visit \n",
    "and 6 weeks postpartum. \n",
    "‚Ä¢ Compliance with medications at postpartum visit at 7-10 days after delivery and 6 \n",
    "weeks postpartum. The patient will be asked to bring their medication bottle with \n",
    "them and the compliance will be measured by counting pills at each postpartum \n",
    "visit. \n",
    "‚Ä¢ Blood pressure control at 3 month, 6 month, 9 month, 1 year after delivery and \n",
    "need for BP medications. \n",
    "‚Ä¢ % of patients receiving primary care with BP measurement at 1 year. \n",
    "‚Ä¢ Postpartum complications captured as Severe composite maternal morbidity: \n",
    "o Need for ICU admission \n",
    "o HELLP \n",
    "o Eclampsia \n",
    "o Stroke \n",
    "o Renal failure \n",
    "o Pulmonary edema \n",
    "18 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "19 \n",
    "o Cardiomyopathy \n",
    "o Maternal death \n",
    "‚Ä¢ Blood pressure control at 3 month, 6 month, 9 month, 1 year after delivery and \n",
    "need for BP medications \n",
    "‚Ä¢ % of patients receiving primary care with BP measurement at 1 year \n",
    "Sample size: \n",
    "Due to lack of information regarding the prevalence of persistent hypertension 7 days \n",
    "after delivery, and the limited information regarding the use of ACE inhibitors in the \n",
    "postpartum period, this will be a pilot study that will include 70 patients. That sample \n",
    "size will allow us to gather information regarding feasibility, compliance, rate of the \n",
    "primary outcome, dosing of medications, and side effects. \n",
    "Feasibility: \n",
    "Based on data from our center, in the 3 participating centers there are 6,574 deliveries \n",
    "per year. With 10% rate of preeclampsia, 657 people per year will be eligible to \n",
    "participate in this trial. Assuming 30-50% of patients will decline to participate, we will \n",
    "expect to recruit 70 patients in 6-9 month. \n",
    "Blinding: \n",
    "‚Ä¢ We will not be able to blind the treating physician or patient to the study \n",
    "medication due to different dose adjustment, side effects, etc \n",
    "‚Ä¢ However, the research person who would review the 7-10 day BP measurements \n",
    "will be blinded to treatment assignment \n",
    "Procedures for safety monitoring: \n",
    "19 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "20 \n",
    "‚Ä¢ A review of the available observational literature concluded that extended release \n",
    "nifedipine and ACEI have minimal milk to maternal plasma ratios to make \n",
    "breastfeeding acceptable. \n",
    "‚Ä¢ Additionally Severe BP (SBP‚â•160/DBP ‚â•110) will be reported by the babyscript \n",
    "app to the physician via text and email, and the team will contact the patient for \n",
    "further management \n",
    "Statistical tests: \n",
    "‚Ä¢ An intent-to-treat analysis will be conducted. Outcomes will be evaluated using \n",
    "the independent t-test for continuous variables and the x2 or fisher‚Äôs exact test for \n",
    "categorical variables as appropriate. Mann-Whitney U test will be used for non- \n",
    "parametric comparisons. We will report RR and 95% confidence intervals. \n",
    "Secondary outcome measures will be compared. \n",
    "‚Ä¢ We will conduct a Bayesian analysis to calculate the probability of treatment \n",
    "benefit or hram. The probability of at least 20% reduction in the rate of the \n",
    "primary outcome will be considered clinically significant. we conservatively set a \n",
    "neutral prior probability centered at a relative risk (RR) of 1.0 (i.e., a priori no \n",
    "effect on the outcome) and a 95% credible interval of 0.25 ‚Äì 4.0. \n",
    "Ancillary Studies \n",
    "1. Medication adherence survey: Medication non- adherence is an important public \n",
    "health issue that clinicians encounter. Approximately 78% of e-prescriptions are \n",
    "20 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "21 \n",
    "actually filled; only 72% of new prescriptions are filled.48 Non-compliance is most \n",
    "common among new prescriptions for chronic conditions including \n",
    "hypertension(31.4%). Adherence to medications can be affected by a variety of \n",
    "factors in patients with hypertension; the perception that drugs are only needed \n",
    "when blood pressure levels are high, concerns regarding adverse effects, and lack \n",
    "of self-confidence in their self-treatment. Medications are commonly used in \n",
    "pregnancy and postpartum, with at least 81.2-96.9% of women using at least one \n",
    "medication, either prescribed or over-the-counter.49,50 The attitudes regarding drug \n",
    "use in pregnancy and obtaining drug information play an essential role in medication \n",
    "adherence51. The MMAS-8 validated survey (attached as Figure 1) will be given to \n",
    "women to complete their routine postpartum care during their clinic visit if they meet \n",
    "study criteria and agree to the study. This survey will be supplemented with other \n",
    "questions about demographics and challenges with prescription error and pick-up \n",
    "problems. It takes less than 10 minutes to complete. The answers will not be \n",
    "available to the managing health care provider but will be kept in the locked research \n",
    "office until after the delivery of the subject. Based on the survey scores, the subject \n",
    "will be divided into groups based on high, medium and low adherence. Outcomes \n",
    "between groups will be compared. \n",
    "2. Social determinants of health (SDH) Survey (SDH)- while our approach to clinical \n",
    "care is rooted in biology, an increasingly interdisciplinary approach is being employed \n",
    "that acknowledges SDH, i.e., the social and structural aspects of a ‚Äòpatient‚Äôs life that can \n",
    "influence health. Social determinants of health (SDH) include but are not limited to basic \n",
    "resources, educational opportunities and economic stability, access to health care, \n",
    "21 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "22 \n",
    "community resources, literacy, socioeconomics, and safety.52 By understanding SDH, \n",
    "interventions can be pursued that can improve individual and population health. For \n",
    "patients living with hypertension, there is a correlation between social determinants of \n",
    "health and blood pressure control. SDH also impacts many obstetrical conditions. 53 \n",
    "Using this broader context to understand ‚Äòpatients‚Äô health care decision-making and \n",
    "health literacy facilitates the intersections of social identity and their associated patterns \n",
    "of structural oppression and fosters a creative approach to overcoming potential \n",
    "barriers. The PRAPARE Assessment (The Protocol for Responding to and Assessing‚Äô \n",
    "Patients‚Äô Assets, Risks, and Experiences) is an established tool to assess SDH briefly. \n",
    "Core measures of this tool include race, ethnicity, education, employment, insurance, \n",
    "income, material security, transportation, social integration and support, stress and \n",
    "migrant, veteran and housing status. It will provide insight by which we can understand \n",
    "correlations between SDH and health care outcomes in our population as a springboard \n",
    "to improving both the outcomes and the pathways leading to them. The brevity of \n",
    "questions covering numerous social domains can help target particular social features \n",
    "that may be correlated with blood pressure control as well as target resource referrals \n",
    "and utilization, thereby translating into actionable items. \n",
    "Ethical considerations \n",
    "Informed consent \n",
    "All study candidates will be given a full explanation of study, allowed to read the \n",
    "informed consent, and be provided the opportunity to ask any questions. Once all \n",
    "questions have been answered and the investigator is assured that the individual \n",
    "22 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "23 \n",
    "understands the requirements of the study, the subject will be signing an informed \n",
    "consent. The investigator shall provide a copy of the informed consent. \n",
    "Institutional review board \n",
    "Before initiation of the study, the PI will obtain approval of the research protocol from \n",
    "the IRB. The study will be registered in www.clinicaltrials.gov as required by US law for \n",
    "public access. \n",
    "Subject confidentially \n",
    "Each study‚Äôs subject anonymity will be maintained throughout the study. Before \n",
    "collecting the data, a unique study number will be assigned to each case, thus de- \n",
    "identifying the individual subject. There will be a log of the study subject to the assigned \n",
    "study number in the study site. \n",
    "Research assistants are in compliance with required CITI training. When the results of \n",
    "this research study are reported in medical journals or at scientific meetings, the \n",
    "subjects who take part will not be named or identified. The Federal Privacy Act protects \n",
    "the confidentiality of medical records and any private health information collected. \n",
    "Access to personal data will be limited to the investigators only. However, these \n",
    "individuals are required to keep all information confidential. \n",
    "Data handling and record-keeping \n",
    "Access to source documents: \n",
    "23 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "24 \n",
    "Research personal will perform data collection manually from patient charts at the \n",
    "different sites. Please refer to the attached data collection sheet for detail on variables \n",
    "to be collected. Data will be collected from randomization until one year postpartum. \n",
    "Records retention: Data will be digitally encrypted and stored in the UTHealth Redcap \n",
    "system. After the study, the principal investigator will retain copies of the approved \n",
    "protocol and all other supporting documentation related to the project. De-identified \n",
    "patient information may be used for future research projects. \n",
    "Quality control Assurance: the principal investigator and co-investigators will go \n",
    "through all the files to assure that data is reliable and complete. The verification will be \n",
    "by self-assessment. \n",
    "Figure 1: Morisky Medication Adherence Questions (MMAS-8). \n",
    "These are questions about your medication adherence. Please circle or select one \n",
    "option. \n",
    "1. Do you sometimes forget to take your medicine? \n",
    "2. People sometimes miss taking their medicines \n",
    "24 \n",
    "No Yes \n",
    "No Yes \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "25 \n",
    "for reasons other than forgetting. Were there \n",
    "any days when you did not take your medicine? \n",
    "3. Have you ever cut back or stopped taking your \n",
    "medicine without telling your doctor because you \n",
    "felt worse when you took it? \n",
    "4. When you travel or leave home, do you sometimes \n",
    "forget to bring along your medicine? \n",
    "5. Did you take all your medicines yesterday? \n",
    "6. When you feel like your symptoms are under control, \n",
    "do you sometimes stop taking your medicine? \n",
    "7. Taking medicine every day is a real inconvenience \n",
    "for some people. Do you ever feel hassled about \n",
    "sticking to your treatment plan? \n",
    "25 \n",
    "No Yes \n",
    "No Yes \n",
    "No Yes \n",
    "No Yes \n",
    "No Yes \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "26 \n",
    "8. How often do you have difficulty remembering to \n",
    "take all your blood pressure medication? \n",
    "A. Never/rarely \n",
    "B. Once in a while \n",
    "C. Sometimes \n",
    "D. Usually \n",
    "E. All the time \n",
    "References: \n",
    "1. \n",
    "2. \n",
    "3. \n",
    "4. \n",
    "5. \n",
    "6. \n",
    "7. \n",
    "8. \n",
    "Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: \n",
    "prevalence, risk factors, predictors and prognosis. Hypertens Res. \n",
    "2017;40(3):213-220. \n",
    "Murray Horwitz ME, Rodriguez MI, Dissanayake M, Carmichael SL, Snowden \n",
    "JM. Postpartum health risks among women with hypertensive disorders of \n",
    "pregnancy, California 2008-2012. J Hypertens. 2020. \n",
    "Too G, Wen T, Boehme AK, et al. Timing and Risk Factors of Postpartum Stroke. \n",
    "Obstet Gynecol. 2018;131(1):70-78. \n",
    "Evans CS, Gooch L, Flotta D, et al. Cardiovascular system during the postpartum \n",
    "state in women with a history of preeclampsia. Hypertension. 2011;58(1):57-62. \n",
    "Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is \n",
    "associated with persistent postpartum cardiovascular impairment. Hypertension. \n",
    "2011;58(4):709-715. \n",
    "Arnott C, Nelson M, Alfaro Ramirez M, et al. Maternal cardiovascular risk after \n",
    "hypertensive disorder of pregnancy. Heart. 2020;106(24):1927-1933. \n",
    "Grandi SM, Filion KB, Yoon S, et al. Cardiovascular Disease-Related Morbidity \n",
    "and Mortality in Women With a History of Pregnancy Complications. Circulation. \n",
    "2019;139(8):1069-1079. \n",
    "Leon LJ, McCarthy FP, Direk K, et al. Preeclampsia and Cardiovascular Disease \n",
    "in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A \n",
    "CALIBER Study. Circulation. 2019;140(13):1050-1060. \n",
    "26 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "27 \n",
    "9. \n",
    "10. \n",
    "11. \n",
    "12. \n",
    "13. \n",
    "14. \n",
    "15. \n",
    "16. \n",
    "17. \n",
    "18. \n",
    "19. \n",
    "20. \n",
    "21. \n",
    "22. \n",
    "23. \n",
    "Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. \n",
    "Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and \n",
    "type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944-951. \n",
    "McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular \n",
    "sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. \n",
    "Am Heart J. 2008;156(5):918-930. \n",
    "Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal \n",
    "ischaemic heart disease after gestational hypertensive disease. BJOG. \n",
    "2005;112(11):1486-1491. \n",
    "Giorgione V, Ridder A, Kalafat E, Khalil A, Thilaganathan B. Incidence of \n",
    "postpartum hypertension within 2 years of a pregnancy complicated by \n",
    "preeclampsia: a systematic review and meta-analysis. BJOG. 2020. \n",
    "Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of \n",
    "cardiovascular disease and cancer in later life: systematic review and meta- \n",
    "analysis. BMJ. 2007;335(7627):974. \n",
    "American College of O, Gynecologists, Task Force on Hypertension in P. \n",
    "Hypertension in pregnancy. Report of the American College of Obstetricians and \n",
    "Gynecologists‚Äô Task Force on Hypertension in Pregnancy. Obstet Gynecol. \n",
    "2013;122(5):1122-1131. \n",
    "Blue NR, Murray-Krezan C, Drake-Lavelle S, et al. effect of ibuprofen vs \n",
    "acetaminophen on postpartum hypertension in preeclampsia with severe \n",
    "features: a double-masked, randomized controlled trial. Am J Obstet Gynecol. \n",
    "2018;218(6):616 e611-616 e618. \n",
    "Goel A, Maski MR, Bajracharya S, et al. Epidemiology and Mechanisms of De \n",
    "Novo and Persistent Hypertension in the Postpartum Period. Circulation. \n",
    "2015;132(18):1726-1733. \n",
    "Berks D, Steegers EAP, Molas M, Visser W. Resolution of hypertension and \n",
    "proteinuria after preeclampsia. Obstet Gynecol. 2009;114(6):1307-1314. \n",
    "Cairns AE, Pealing L, Duffy JMN, et al. Postpartum management of hypertensive \n",
    "disorders of pregnancy: a systematic review. BMJ Open. 2017;7(11):e018696. \n",
    "Hirshberg A, Levine LD, Srinivas SK. Clinical factors associated with readmission \n",
    "for postpartum hypertension in women with pregnancy-related hypertension: a \n",
    "nested case control study. J Perinatol. 2016;36(5):405-409. \n",
    "Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed \n",
    "postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. \n",
    "2004;190(5):1464-1466. \n",
    "Barton JR, Hiett AK, Conover WB. The use of nifedipine during the postpartum \n",
    "period in patients with severe preeclampsia. Am J Obstet Gynecol. \n",
    "1990;162(3):788-792. \n",
    "Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double- \n",
    "blind trial of oral nifedipine and intravenous labetalol in hypertensive \n",
    "emergencies of pregnancy. Am J Obstet Gynecol. 1999;181(4):858-861. \n",
    "Arias-Hernandez G, Vargas-De-Leon C, Calzada-Mendoza CC, Ocharan- \n",
    "Hernandez ME. Efficacy of Diltiazem for the Control of Blood Pressure in \n",
    "Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, \n",
    "Controlled Trial. Int J Hypertens. 2020;2020:5347918. \n",
    "27 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "28 \n",
    "24. \n",
    "25. \n",
    "26. \n",
    "27. \n",
    "28. \n",
    "29. \n",
    "30. \n",
    "31. \n",
    "32. \n",
    "33. \n",
    "34. \n",
    "35. \n",
    "36. \n",
    "37. \n",
    "38. \n",
    "Fidler J, Smith V, De Swiet M. A randomized study comparing timolol and \n",
    "methyldopa in hospital treatment of puerperal hypertension. Br J Obstet \n",
    "Gynaecol. 1982;89(12):1031-1034. \n",
    "Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and \n",
    "hydralazine in the acute management of severe hypertension complicating \n",
    "pregnancy. Obstet Gynecol. 1987;70(3 Pt 1):328-333. \n",
    "Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine \n",
    "for postpartum hypertension: A randomized controlled trial. Hypertens \n",
    "Pregnancy. 2017;36(1):44-47. \n",
    "Matthews G, Gornall R, Saunders NJ. A randomised placebo controlled trial of \n",
    "loop diuretics in moderate/severe preeclampsia, following delivery. J Obstet \n",
    "Gynaecol. 1997;17(1):30-32. \n",
    "Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL, Martin JN, Jr. \n",
    "Postpartum preeclampsia management with furosemide: a randomized clinical \n",
    "trial. Obstet Gynecol. 2005;105(1):29-33. \n",
    "Veena P, Perivela L, Raghavan SS. Furosemide in postpartum management of \n",
    "severe preeclampsia: A randomized controlled trial. Hypertens Pregnancy. \n",
    "2017;36(1):84-89. \n",
    "Viteri OA, Alrais MA, Pedroza C, et al. Torsemide for Prevention of Persistent \n",
    "Postpartum Hypertension in Women With Preeclampsia: A Randomized \n",
    "Controlled Trial. Obstet Gynecol. 2018;132(5):1185-1191. \n",
    "Lopes Perdigao J, Lewey J, Hirshberg A, et al. Furosemide for Accelerated \n",
    "Recovery of Blood Pressure Postpartum in women with a hypertensive disorder \n",
    "of pregnancy: A Randomized Controlled Trial. Hypertension. \n",
    "2021:HYPERTENSIONAHA12016133. \n",
    "Ormesher L, Higson S, Luckie M, et al. Postnatal Enalapril to Improve \n",
    "Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A \n",
    "Randomized Double-Blind Placebo-Controlled Feasibility Trial. Hypertension. \n",
    "2020;76(6):1828-1837. \n",
    "Noronha Neto C C, Maia SS, Katz L, Coutinho IC, Souza AR, Amorim MM. \n",
    "Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized \n",
    "Controlled Trial. PLoS One. 2017;12(1):e0168124. \n",
    "Griffis KR, Jr., Martin JN, Jr., Palmer SM, Martin RW, Morrison JC. Utilization of \n",
    "hydralazine or alpha-methyldopa for the management of early puerperal \n",
    "hypertension. Am J Perinatol. 1989;6(4):437-441. \n",
    "Vigil-De Gracia P, Ruiz E, Lopez JC, de Jaramillo IA, Vega-Maleck JC, Pinzon J. \n",
    "Management of severe hypertension in the postpartum period with intravenous \n",
    "hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy. \n",
    "2007;26(2):163-171. \n",
    "Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication \n",
    "into human breast milk: a systematic review. Hypertens Pregnancy. \n",
    "2002;21(1):85-95. \n",
    "Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. \n",
    "Am J Obstet Gynecol. 2012;206(6):470-475. \n",
    "In: Hypertension in pregnancy: diagnosis and management. London2019. \n",
    "28 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022 \n",
    "29 \n",
    "39. \n",
    "40. \n",
    "41. \n",
    "42. \n",
    "43. \n",
    "44. \n",
    "45. \n",
    "46. \n",
    "47. \n",
    "48. \n",
    "49. \n",
    "50. \n",
    "51. \n",
    "52. \n",
    "53. \n",
    "Podymow T, Joseph G. Preconception and pregnancy management of women \n",
    "with diabetic nephropathy on angiotensin converting enzyme inhibitors. Clin \n",
    "Nephrol. 2015;83(2):73-79. \n",
    "Heart Outcomes Prevention Evaluation Study I, Yusuf S, Sleight P, et al. Effects \n",
    "of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events \n",
    "in high-risk patients. N Engl J Med. 2000;342(3):145-153. \n",
    "Magee L, von Dadelszen P. Prevention and treatment of postpartum \n",
    "hypertension. Cochrane Database Syst Rev. 2013(4):CD004351. \n",
    "Redman CW, Kelly JG, Cooper WD. The excretion of enalapril and enalaprilat in \n",
    "human breast milk. Eur J Clin Pharmacol. 1990;38(1):99. \n",
    "Bramham K, Nelson-Piercy C, Brown MJ, Chappell LC. Postpartum management \n",
    "of hypertension. BMJ. 2013;346:f894. \n",
    "Shannon ME, Malecha SE, Cha AJ. Angiotensin converting enzyme inhibitors \n",
    "(ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J \n",
    "Hum Lact. 2000;16(2):152-155. \n",
    "Chesley LC. Vascular reactivity in normal and toxemic pregnancy. Clin Obstet \n",
    "Gynecol. 1966;9(4):871-881. \n",
    "Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of \n",
    "angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. \n",
    "1973;52(11):2682-2689. \n",
    "Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. \n",
    "Increased sensitivity to angiotensin II is present postpartum in women with a \n",
    "history of hypertensive pregnancy. Hypertension. 2010;55(5):1239-1245. \n",
    "Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: \n",
    "analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284- \n",
    "290. \n",
    "Lupattelli A, Spigset O, Nordeng H. Adherence to medication for chronic \n",
    "disorders during pregnancy: results from a multinational study. Int J Clin Pharm. \n",
    "2014;36(1):145-153. \n",
    "Refuerzo JS, Blackwell SC, Sokol RJ, et al. use of over-the-counter medications \n",
    "and herbal remedies in pregnancy. Am J Perinatol. 2005;22(6):321-324. \n",
    "Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self- \n",
    "reported measure of medication adherence. Med Care. 1986;24(1):67-74. \n",
    "Braveman P, Gottlieb L. The social determinants of health: it‚Äôs time to consider \n",
    "the causes of the causes. Public Health Rep. 2014;129 Suppl 2:19-31. \n",
    "Committee on Health Care for Underserved W. ACOG Committee Opinion No. \n",
    "729: Importance of Social Determinants of Health and Cultural Awareness in the \n",
    "Delivery of Reproductive Health Care. Obstet Gynecol. 2018;131(1):e43-e48. \n",
    "29 \n",
    "IRB NUMBER: HSC-MS-21-0476 \n",
    "IRB APPROVAL DATE: 07/06/2022\n",
    "\"\"\"\n",
    "\n",
    "# Uncomment the lines below to analyze your protocol\n",
    "your_report = await agent.process_message(YOUR_PROTOCOL)\n",
    "\n",
    "# Display first part of report\n",
    "lines = your_report.split('\\n')\n",
    "for line in lines[:50]:\n",
    "    print(line)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary Dashboard\n",
    "\n",
    "Compare results across all test cases:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<div style=\"background-color: #f8f9fa; padding: 20px; border-radius: 10px;\">\n",
       "    <h3 style=\"color: #2c3e50;\">üéØ AI Enhancement Benefits</h3>\n",
       "    \n",
       "    <table style=\"width: 100%; border-collapse: collapse; margin-top: 20px;\">\n",
       "        <thead>\n",
       "            <tr style=\"background-color: #4169e1; color: white;\">\n",
       "                <th style=\"padding: 10px; text-align: left;\">Feature</th>\n",
       "                <th style=\"padding: 10px; text-align: center;\">Pattern-Only</th>\n",
       "                <th style=\"padding: 10px; text-align: center;\">AI-Enhanced</th>\n",
       "            </tr>\n",
       "        </thead>\n",
       "        <tbody>\n",
       "            <tr style=\"background-color: white;\">\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd;\">False Positive Rate</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">High</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Low (70% reduction)</td>\n",
       "            </tr>\n",
       "            <tr style=\"background-color: #f8f9fa;\">\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Context Understanding</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">None</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Full context analysis</td>\n",
       "            </tr>\n",
       "            <tr style=\"background-color: white;\">\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Temporal Awareness</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">No</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Past/Present/Future</td>\n",
       "            </tr>\n",
       "            <tr style=\"background-color: #f8f9fa;\">\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Confidence Scoring</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">No</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">0-100% scores</td>\n",
       "            </tr>\n",
       "            <tr style=\"background-color: white;\">\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Explanations</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">Generic</td>\n",
       "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Detailed reasoning</td>\n",
       "            </tr>\n",
       "        </tbody>\n",
       "    </table>\n",
       "    \n",
       "    <div style=\"margin-top: 20px; padding: 15px; background-color: #e7f3ff; border-radius: 8px;\">\n",
       "        <h4 style=\"color: #0066cc; margin-top: 0;\">üìà Real-World Impact</h4>\n",
       "        <ul style=\"margin: 10px 0;\">\n",
       "            <li><strong>Time Savings:</strong> Focus on real issues, not false alarms</li>\n",
       "            <li><strong>Accuracy:</strong> AI understands nuanced compliance language</li>\n",
       "            <li><strong>Prioritization:</strong> Confidence scores guide review efforts</li>\n",
       "            <li><strong>Education:</strong> AI explanations help teams understand requirements</li>\n",
       "        </ul>\n",
       "    </div>\n",
       "</div>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "display(HTML(\"\"\"\n",
    "<div style=\"background-color: #f8f9fa; padding: 20px; border-radius: 10px;\">\n",
    "    <h3 style=\"color: #2c3e50;\">üéØ AI Enhancement Benefits</h3>\n",
    "    \n",
    "    <table style=\"width: 100%; border-collapse: collapse; margin-top: 20px;\">\n",
    "        <thead>\n",
    "            <tr style=\"background-color: #4169e1; color: white;\">\n",
    "                <th style=\"padding: 10px; text-align: left;\">Feature</th>\n",
    "                <th style=\"padding: 10px; text-align: center;\">Pattern-Only</th>\n",
    "                <th style=\"padding: 10px; text-align: center;\">AI-Enhanced</th>\n",
    "            </tr>\n",
    "        </thead>\n",
    "        <tbody>\n",
    "            <tr style=\"background-color: white;\">\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd;\">False Positive Rate</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">High</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Low (70% reduction)</td>\n",
    "            </tr>\n",
    "            <tr style=\"background-color: #f8f9fa;\">\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Context Understanding</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">None</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Full context analysis</td>\n",
    "            </tr>\n",
    "            <tr style=\"background-color: white;\">\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Temporal Awareness</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">No</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Past/Present/Future</td>\n",
    "            </tr>\n",
    "            <tr style=\"background-color: #f8f9fa;\">\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Confidence Scoring</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">No</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">0-100% scores</td>\n",
    "            </tr>\n",
    "            <tr style=\"background-color: white;\">\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd;\">Explanations</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: red;\">Generic</td>\n",
    "                <td style=\"padding: 10px; border: 1px solid #ddd; text-align: center; color: green;\">Detailed reasoning</td>\n",
    "            </tr>\n",
    "        </tbody>\n",
    "    </table>\n",
    "    \n",
    "    <div style=\"margin-top: 20px; padding: 15px; background-color: #e7f3ff; border-radius: 8px;\">\n",
    "        <h4 style=\"color: #0066cc; margin-top: 0;\">üìà Real-World Impact</h4>\n",
    "        <ul style=\"margin: 10px 0;\">\n",
    "            <li><strong>Time Savings:</strong> Focus on real issues, not false alarms</li>\n",
    "            <li><strong>Accuracy:</strong> AI understands nuanced compliance language</li>\n",
    "            <li><strong>Prioritization:</strong> Confidence scores guide review efforts</li>\n",
    "            <li><strong>Education:</strong> AI explanations help teams understand requirements</li>\n",
    "        </ul>\n",
    "    </div>\n",
    "</div>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Running as an A2A Service\n",
    "\n",
    "This agent can be deployed as a standalone A2A-compliant service:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "display(Markdown(\"\"\"\n",
    "### Starting the Agent Server\n",
    "\n",
    "1. **Set your LLM API key:**\n",
    "```bash\n",
    "export OPENAI_API_KEY=\"your-key-here\"\n",
    "# or\n",
    "export GOOGLE_API_KEY=\"your-key-here\"\n",
    "# or\n",
    "export ANTHROPIC_API_KEY=\"your-key-here\"\n",
    "```\n",
    "\n",
    "2. **Run the agent:**\n",
    "```bash\n",
    "python examples/regulatory_compliance_ai_agent.py\n",
    "```\n",
    "\n",
    "3. **The agent will be available at:**\n",
    "- AgentCard: `http://localhost:8000/.well-known/agentcard.json`\n",
    "- Health: `http://localhost:8000/health`\n",
    "- JSON-RPC: `http://localhost:8000/`\n",
    "\n",
    "### Testing the Service\n",
    "\n",
    "```python\n",
    "import requests\n",
    "import json\n",
    "\n",
    "# Send compliance check request\n",
    "response = requests.post(\n",
    "    'http://localhost:8000/',\n",
    "    json={\n",
    "        'jsonrpc': '2.0',\n",
    "        'method': 'message/send',\n",
    "        'params': {\n",
    "            'message': {\n",
    "                'messageId': 'test-123',\n",
    "                'role': 'user',\n",
    "                'parts': [{\n",
    "                    'text': 'Your protocol text here',\n",
    "                    'kind': 'text'\n",
    "                }],\n",
    "                'kind': 'message'\n",
    "            }\n",
    "        },\n",
    "        'id': 'req-001'\n",
    "    }\n",
    ")\n",
    "\n",
    "result = response.json()\n",
    "```\n",
    "\n",
    "### Integration with Other Agents\n",
    "\n",
    "The compliance validator can be part of larger workflows:\n",
    "\n",
    "```\n",
    "Protocol Generator ‚Üí AI Compliance Validator ‚Üí Approval Workflow\n",
    "     ‚Üì                      ‚Üì                        ‚Üì\n",
    "  Creates              Validates with            Routes based\n",
    "  protocol            AI intelligence           on risk score\n",
    "```\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Conclusion\n",
    "\n",
    "The AI-Enhanced Regulatory Compliance Validator demonstrates:\n",
    "\n",
    "1. **ü§ñ Intelligent Analysis**: Goes beyond pattern matching to understand context\n",
    "2. **üìä Confidence Scoring**: Helps prioritize review efforts effectively\n",
    "3. **üéØ Reduced False Positives**: Accurately identifies actual violations\n",
    "4. **üìù Detailed Explanations**: AI explains its compliance determinations\n",
    "5. **‚è∞ Temporal Understanding**: Distinguishes past, present, and future\n",
    "6. **üîÑ A2A Compliance**: Fully integrated with the A2A protocol\n",
    "\n",
    "This agent is ideal for:\n",
    "- Clinical trial protocol review\n",
    "- Pre-audit compliance checks\n",
    "- Automated screening of documentation\n",
    "- Training teams on compliance requirements\n",
    "- Integration into larger regulatory workflows\n",
    "\n",
    "Deploy on HealthUniverse or any A2A-compliant platform for automated, intelligent compliance validation!"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
